{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "3f7343b9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import pdfplumber\n",
    "import pandas as pd\n",
    "from transformers import pipeline\n",
    "\n",
    "# Set the path to the folder containing the PDF files\n",
    "pdf_folder = '/Users/amin/Desktop/33/test'\n",
    "\n",
    "# Initialize the OpenAI GPT-based question-answering pipeline\n",
    "question_answering = pipeline(\"question-answering\", model=\"deepset/roberta-base-squad2\", tokenizer=\"deepset/roberta-base-squad2\")\n",
    "\n",
    "def get_chunks(text, max_tokens=2048):\n",
    "    tokens = text.split()\n",
    "    chunks = []\n",
    "    current_chunk = []\n",
    "\n",
    "    for token in tokens:\n",
    "        if len(current_chunk) + len(token) < max_tokens:\n",
    "            current_chunk.append(token)\n",
    "        else:\n",
    "            chunks.append(\" \".join(current_chunk))\n",
    "            current_chunk = [token]\n",
    "\n",
    "    if current_chunk:\n",
    "        chunks.append(\" \".join(current_chunk))\n",
    "\n",
    "    return chunks\n",
    "\n",
    "def find_disease_keywords(chunks, question_answering_pipeline):\n",
    "    question = \"What are the 3 main disease-related keywords?\"\n",
    "    best_score = 0\n",
    "    best_answer = None\n",
    "\n",
    "    for chunk in chunks:\n",
    "        answer = question_answering_pipeline(question=question, context=chunk)\n",
    "        if answer[\"score\"] > best_score:\n",
    "            best_score = answer[\"score\"]\n",
    "            best_answer = answer[\"answer\"]\n",
    "\n",
    "    return best_answer\n",
    "\n",
    "results = []\n",
    "\n",
    "for pdf_file in os.listdir(pdf_folder):\n",
    "    if pdf_file.endswith(\".pdf\"):\n",
    "        with pdfplumber.open(os.path.join(pdf_folder, pdf_file)) as pdf:\n",
    "            text = \"\"\n",
    "            for page in pdf.pages:\n",
    "                text += page.extract_text()\n",
    "\n",
    "            chunks = get_chunks(text)\n",
    "            disease_keywords = find_disease_keywords(chunks, question_answering)\n",
    "            results.append({\"File\": pdf_file[:-4], \"Issue_KW\": disease_keywords})\n",
    "\n",
    "df = pd.DataFrame(results)\n",
    "df.to_csv(\"Issue_KW.csv\", index=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "3673e79c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>File</th>\n",
       "      <th>Issue_KW</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Zehna Corporate Deck SymBiosis</td>\n",
       "      <td>saline, FMC, ZTx101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>PS_TCRR_NOTE_1.5.23</td>\n",
       "      <td>Accelerating next-gen TC-510 and TC-520</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Grace Sciece Platform (9.2.20)</td>\n",
       "      <td>Parkinson’s (1MM patients in U.S.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>AcuamarkDx Series A_Corp Deck</td>\n",
       "      <td>Proprietary and Confidential</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>coding.bio_deck</td>\n",
       "      <td>Distance T cell to epitope ● Signaling domains...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Centurion_BioPharma-Non-Confidential_2021_2</td>\n",
       "      <td>ology and diagnostics</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>JPM_SRZN_NOTE_11.28.22</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>G_ACET_IOC_4.8.21</td>\n",
       "      <td>HLA-independence overcoming loss of HLA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>C_ARQT_NOTE_11.15.22</td>\n",
       "      <td>Underperform</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>B_RXRX_IOC_9.21.21</td>\n",
       "      <td>Batten disease and CMT2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Dianomi Non-Confidential Slides - v3</td>\n",
       "      <td>akinra+MCMs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>KBC_MAAT.FR_IOC_12.14.21</td>\n",
       "      <td>Accept the Offer, Black Out, No Recommendation...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Engrail Therapeutics</td>\n",
       "      <td>Do not duplicate or further distributeEngrail</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>WB_VOR_IOC_1.25.22</td>\n",
       "      <td>disease incidence, treatment-related mortality...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>E_FNCH_IOC_8.10.21</td>\n",
       "      <td>High dose, Low dose, and Pbo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>CG_GRNA_IOC_12.8.22</td>\n",
       "      <td>resistance, residues, and regulations</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>LT_AVXL_NOTE_6.22.21</td>\n",
       "      <td>Commitments and Contingencies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>LT_PHGE_IOC_4.15.21</td>\n",
       "      <td>antibacterial therapeutic; and lysogenic (or t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Graviton Corporate Presentation July 2022</td>\n",
       "      <td>autoantibodies and secretion of profibrotic fa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Bectas Tx Non-Con - Aug.1.2022</td>\n",
       "      <td>scientific expertise and strong operational ex...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>20 080822_PRTA_Research Summary</td>\n",
       "      <td>digital measures of motor function</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>CT one-pager Dec 22</td>\n",
       "      <td>sleep of circadian rhythms</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>221003_PRE_Numab Non-Confidential Presentation</td>\n",
       "      <td>IND-READY TECHNOLOGY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>2022-3-18 Apeximmune non-confidential Baird</td>\n",
       "      <td>Superior In Vitro T cell 2. Unique Binding Epi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Alto Overview_April 2022</td>\n",
       "      <td>3.5 3 2.5 2 1.5 1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>[NON-NDA] Integral Overview</td>\n",
       "      <td>BUILD, INTEGRATE, DISCOVER, DEVELOP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>JMP_NXTC_IOC_5.26.20</td>\n",
       "      <td>chills, injection site pain and fatigue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Flare Non-Con Deck November 2022</td>\n",
       "      <td>…BUT, HARD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>AscelpiX Corporate Presentation NON CONFIDENTI...</td>\n",
       "      <td>CONFIDENTIALnAMD (Neovascular AMD) and DME Neo...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                 File  \\\n",
       "0                      Zehna Corporate Deck SymBiosis   \n",
       "1                                 PS_TCRR_NOTE_1.5.23   \n",
       "2                      Grace Sciece Platform (9.2.20)   \n",
       "3                       AcuamarkDx Series A_Corp Deck   \n",
       "4                                     coding.bio_deck   \n",
       "5         Centurion_BioPharma-Non-Confidential_2021_2   \n",
       "6                              JPM_SRZN_NOTE_11.28.22   \n",
       "7                                   G_ACET_IOC_4.8.21   \n",
       "8                                C_ARQT_NOTE_11.15.22   \n",
       "9                                  B_RXRX_IOC_9.21.21   \n",
       "10               Dianomi Non-Confidential Slides - v3   \n",
       "11                           KBC_MAAT.FR_IOC_12.14.21   \n",
       "12                               Engrail Therapeutics   \n",
       "13                                 WB_VOR_IOC_1.25.22   \n",
       "14                                 E_FNCH_IOC_8.10.21   \n",
       "15                                CG_GRNA_IOC_12.8.22   \n",
       "16                               LT_AVXL_NOTE_6.22.21   \n",
       "17                                LT_PHGE_IOC_4.15.21   \n",
       "18          Graviton Corporate Presentation July 2022   \n",
       "19                     Bectas Tx Non-Con - Aug.1.2022   \n",
       "20                    20 080822_PRTA_Research Summary   \n",
       "21                                CT one-pager Dec 22   \n",
       "22     221003_PRE_Numab Non-Confidential Presentation   \n",
       "23        2022-3-18 Apeximmune non-confidential Baird   \n",
       "24                           Alto Overview_April 2022   \n",
       "25                        [NON-NDA] Integral Overview   \n",
       "26                               JMP_NXTC_IOC_5.26.20   \n",
       "27                   Flare Non-Con Deck November 2022   \n",
       "28  AscelpiX Corporate Presentation NON CONFIDENTI...   \n",
       "\n",
       "                                             Issue_KW  \n",
       "0                                 saline, FMC, ZTx101  \n",
       "1             Accelerating next-gen TC-510 and TC-520  \n",
       "2                  Parkinson’s (1MM patients in U.S.)  \n",
       "3                        Proprietary and Confidential  \n",
       "4   Distance T cell to epitope ● Signaling domains...  \n",
       "5                               ology and diagnostics  \n",
       "6                                                   2  \n",
       "7             HLA-independence overcoming loss of HLA  \n",
       "8                                        Underperform  \n",
       "9                            Batten disease and CMT2A  \n",
       "10                                        akinra+MCMs  \n",
       "11  Accept the Offer, Black Out, No Recommendation...  \n",
       "12      Do not duplicate or further distributeEngrail  \n",
       "13  disease incidence, treatment-related mortality...  \n",
       "14                       High dose, Low dose, and Pbo  \n",
       "15              resistance, residues, and regulations  \n",
       "16                      Commitments and Contingencies  \n",
       "17  antibacterial therapeutic; and lysogenic (or t...  \n",
       "18  autoantibodies and secretion of profibrotic fa...  \n",
       "19  scientific expertise and strong operational ex...  \n",
       "20                 digital measures of motor function  \n",
       "21                         sleep of circadian rhythms  \n",
       "22                               IND-READY TECHNOLOGY  \n",
       "23  Superior In Vitro T cell 2. Unique Binding Epi...  \n",
       "24                                  3.5 3 2.5 2 1.5 1  \n",
       "25                BUILD, INTEGRATE, DISCOVER, DEVELOP  \n",
       "26            chills, injection site pain and fatigue  \n",
       "27                                         …BUT, HARD  \n",
       "28  CONFIDENTIALnAMD (Neovascular AMD) and DME Neo...  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.to_csv('df6.csv', index=False)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "bb75b6cc",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                                 File  \\\n",
      "0                      Zehna Corporate Deck SymBiosis   \n",
      "1                                 PS_TCRR_NOTE_1.5.23   \n",
      "2                      Grace Sciece Platform (9.2.20)   \n",
      "3                       AcuamarkDx Series A_Corp Deck   \n",
      "4                                     coding.bio_deck   \n",
      "5         Centurion_BioPharma-Non-Confidential_2021_2   \n",
      "6                              JPM_SRZN_NOTE_11.28.22   \n",
      "7                                   G_ACET_IOC_4.8.21   \n",
      "8                                C_ARQT_NOTE_11.15.22   \n",
      "9                                  B_RXRX_IOC_9.21.21   \n",
      "10               Dianomi Non-Confidential Slides - v3   \n",
      "11                           KBC_MAAT.FR_IOC_12.14.21   \n",
      "12                               Engrail Therapeutics   \n",
      "13                                 WB_VOR_IOC_1.25.22   \n",
      "14                                 E_FNCH_IOC_8.10.21   \n",
      "15                                CG_GRNA_IOC_12.8.22   \n",
      "16                               LT_AVXL_NOTE_6.22.21   \n",
      "17                                LT_PHGE_IOC_4.15.21   \n",
      "18          Graviton Corporate Presentation July 2022   \n",
      "19                     Bectas Tx Non-Con - Aug.1.2022   \n",
      "20                    20 080822_PRTA_Research Summary   \n",
      "21                                CT one-pager Dec 22   \n",
      "22     221003_PRE_Numab Non-Confidential Presentation   \n",
      "23        2022-3-18 Apeximmune non-confidential Baird   \n",
      "24                           Alto Overview_April 2022   \n",
      "25                        [NON-NDA] Integral Overview   \n",
      "26                               JMP_NXTC_IOC_5.26.20   \n",
      "27                   Flare Non-Con Deck November 2022   \n",
      "28  AscelpiX Corporate Presentation NON CONFIDENTI...   \n",
      "\n",
      "                           Issue  \n",
      "0         Vaccines or infectious  \n",
      "1   Cancer or tumors or oncology  \n",
      "2                   Neurological  \n",
      "3                          Other  \n",
      "4         Vaccines or infectious  \n",
      "5   Cancer or tumors or oncology  \n",
      "6         Vaccines or infectious  \n",
      "7   Cancer or tumors or oncology  \n",
      "8                          Other  \n",
      "9                   Neurological  \n",
      "10  Cancer or tumors or oncology  \n",
      "11                         Other  \n",
      "12                         Other  \n",
      "13  Cancer or tumors or oncology  \n",
      "14  Cancer or tumors or oncology  \n",
      "15                         Other  \n",
      "16                        Mental  \n",
      "17        Vaccines or infectious  \n",
      "18  Cancer or tumors or oncology  \n",
      "19  Cancer or tumors or oncology  \n",
      "20                  Neurological  \n",
      "21                  Neurological  \n",
      "22                         Other  \n",
      "23  Cancer or tumors or oncology  \n",
      "24        Vaccines or infectious  \n",
      "25                         Other  \n",
      "26        Vaccines or infectious  \n",
      "27                  Neurological  \n",
      "28                  Neurological  \n"
     ]
    }
   ],
   "source": [
    "import configparser\n",
    "import pandas as pd\n",
    "import openai\n",
    "import re\n",
    "\n",
    "def load_openai_api_key():\n",
    "    config = configparser.ConfigParser()\n",
    "    config.read(\"config.ini\")\n",
    "    return config[\"openai\"][\"api_key\"]\n",
    "\n",
    "def find_matching_area(answer):\n",
    "    areas = [\n",
    "        \"Vaccines or infectious\",\n",
    "        \"Gastrointestinal or metabolism\",\n",
    "        \"Neurological\",\n",
    "        \"Cancer or tumors or oncology\",\n",
    "        \"Dermatological\",\n",
    "        \"Organ health\",\n",
    "        \"Mental\",\n",
    "        \"Other\",\n",
    "    ]\n",
    "    for area in areas:\n",
    "        if re.search(area.lower(), answer.lower()):\n",
    "            return area\n",
    "    return \"Other\"\n",
    "\n",
    "def get_related_area(keywords):\n",
    "    openai.api_key = load_openai_api_key()\n",
    "    prompt = f\"Which of the following areas is more related to the keywords: {keywords}?\\n\\nAreas:\\n\" \\\n",
    "             \"Vaccines or infectious\\n\" \\\n",
    "             \"Gastrointestinal or metabolism\\n\" \\\n",
    "             \"Neurological\\n\" \\\n",
    "             \"Cancer or tumors or oncology\\n\" \\\n",
    "             \"Dermatological\\n\" \\\n",
    "             \"Organ health\\n\" \\\n",
    "             \"Mental\\n\" \\\n",
    "             \"Other\\n\\nAnswer: \"\n",
    "\n",
    "    response = openai.Completion.create(\n",
    "        engine=\"text-davinci-002\",\n",
    "        prompt=prompt,\n",
    "        max_tokens=10,\n",
    "        n=1,\n",
    "        stop=None,\n",
    "        temperature=0.5,\n",
    "    )\n",
    "\n",
    "    answer = response.choices[0].text.strip()\n",
    "    matching_area = find_matching_area(answer)\n",
    "    return matching_area\n",
    "\n",
    "def main():\n",
    "    # Load your DataFrame\n",
    "    df = pd.read_csv(\"df6.csv\")\n",
    "\n",
    "    # Add a new column 'Issue'\n",
    "    df[\"Issue\"] = df[\"Issue_KW\"].apply(get_related_area)\n",
    "\n",
    "    # Drop the 'KW' column\n",
    "    df = df.drop(columns=[\"Issue_KW\"])\n",
    "    print(df)\n",
    "\n",
    "    # Save the DataFrame to a new CSV file\n",
    "    df.to_csv(\"issue6.csv\", index=False)\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f6096a83",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
